# Trial Master File
Please include your project files in the appropriate subfolders.

## A. Correspondence
A1: Covering letter submitting party dd dd-mm-yy (see model letter)\
A2: Authorisation letter from the sponsor dd dd-mm-yy (if the submitting party is not the sponsor)\
A3: Confirmation e-mail EudraCT number dd dd-mm-yy

## B. Forms
B1: ABR form version ... dd dd-mm-yy (see ToetsingOnline)\
B2: Local addendum to the ABR form (if applicable)\
B3: EudraCT application form dd dd-mm-yy\
B4: Gene therapy/GMO form dd dd-mm-yy (if applicable)\
B5: EudraCT form notification of amendment dd dd-mm-yy\
B5: Notification of the addition of a centre [name centre] dd dd-mm-yy B7: EudraCT end of trial form dd dd-mm-yy

## C. Protocol and amendments
C1: Research protocol NLxxxxx.xxx.xx, version ... dd dd-mm-yy\
C2: Amendment version ... dd dd-mm-yy

## D. Product information
D1: IB [name product] version ... dd dd-mm-yy\
D1. Survey list of SUSARs dd dd-mm-yy (only concerning SUSARs after the IB date) \
D2: IMPD [name product] version ... dd dd-mm-yy\
D2: IMDD [name product] version ... dd dd-mm-yy (if applicable)\
D2: List of relevant trials dd dd-mm-yy\
D3: Example lables in Dutch version ... dd dd-mm-yy\
D4: GMP-declaration dd dd-mm-yy (if applicable)\
D5: Product information hospital pharmacist (if applicable)\
D6. Additional product data (type of document)

## E. Information for the research subjects
E1/E2: Research subject/representative information leaflet including the consent form(s) version ... dd dd-mm-yy\
E3: Advertising texts or other recruitment material version ... dd dd-mm-yy (if applicable, type of document)\
E4: Information materials version ... dd dd-mm-yy (if applicable, type of document)

## F. Questionnaires, patient diaries, patient cards, etc. (if applicable) 
F1: [Type of questionnaire] version ... dd dd-mm-yy\
F2: Patient diary version ... dd dd-mm-yy\
F3: Patient card version ... dd dd-mm-yy\
F4: Other documents (type of document) dd dd-mm-yy

## G. Insurance information
G1: Insurance certificate for WMO research with human subject insurance dd dd-mm- yy\
G1. Declaration of human subjects insurance dd dd-mm-yy (if applicable)\
G2: Proof of coverage of investigator or sponsor, for example liability insurance [name sponsor/centre] dd dd-mm-yy

## H. CVs
H1: CV independent expert [name centre], [name expert] dd dd-mm-yy \
H2: CV coordinating investigator [name investigator] dd dd-mm-yy

## I. Information per participating centre in the Netherlands
I1: List of participating centres and principal investigators per centre dd dd-mm-yy \
I2: Research declaration [name centre] dd dd-mm-yy\
I3: CV of the principal investigator [name centre], [name investigator] dd dd-mm-yy \
I4: Other information per participating centre (if applicable)

## J. Additional information regarding financial compensation
J1: Information on compensation for research subjects dd dd-mm-yy\
J2: Information on compensation for investigators and centres dd dd-mm-yy

## K. Other relevant documents
K1: Copy of reviews by other institutions [name institutions], dd dd-mm-yy (e.g. grant giving body or recommendations by EMA, FDA etc.)\
K2: Overview foreign competent authorities together with copy of reviews by foreign MRECs/ECs or authorised authorities dd dd-mm-yy (including VHP)\
K3: Clinical trial agreement from sponsor or funder and the investigator and/or institution version ...\
K4: Scientific publications [author, year, journal, volume, pages] dd dd-mm-yy\
K5: Data Safety Monitoring Board (DSMB) [composition, charter, advise] version ... dd dd-mm-yy (if applicable)\
K6: Other documents (if applicable, type of document)

## L. Safety information
L1: SUSARs ....... dd dd-mm-yy\
L2: Periodic line listings SUSARs [name product] dd [from dd-mm-yy to dd-mm-yy] \
L3: Development Safety Update Reports [name product] dd dd-mm-yy\
L4: SAEs ....... dd dd-mm-yy\
L5: Periodic line listings SAEs [name product] dd [from dd-mm-yy to dd-mm-yy] \
L6: Other relevant safety information [type document] dd dd-mm-yy

## M. Progress reports and research results
M1: Progress report dd dd-mm-yy\
M2: Summary of research results/scientific publications dd dd-mm-yy \
M3: Clinical trial report dd dd-mm-yy